PMID: 2489002Jan 1, 1989Paper

Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis

Acta Leidensia
H J Rim, K H Joo

Abstract

Thirty-three patients with confirmed cysticercosis, with or without cerebral involvement, were treated with praziquantel at a daily dose of 75 mg/kg tid for 3 to 10 consecutive days and evaluated for tolerance and therapeutic effects. For dermal cysticercosis, a daily dose of 75 mg/kg tid for 3 days is effective. The nodules disappeared in one to 12 months after treatment. Twenty out of 33 patients with cysticercosis had cerebral cysticercosis. Among these 20 cases, 13 had epileptic seizures, 6 had a combination of both epileptic seizures and intracranial hypertension, and one had headache. The efficacy of the treatment of cerebral cysticercosis was assessed by the frequency of convulsions before and after treatment, and by the disappearance or decreased densities of the cystic lesions at brain CT scanning (6 months follow up). A daily dose of 75 mg/kg tid for 7 to 10 days (total 525 to 750 mg/kg) seems to be effective for the treatment of cerebral cysticercosis. The concomitant oral administration of dexamethasone during the course of treatment was effective for preventing and minimizing side effects. Praziquantel was very well tolerated.

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Kisaengch'unghak chapchi. The Korean journal of parasitology
Han Jong RimChang Yun Park
The Southeast Asian Journal of Tropical Medicine and Public Health
E M QuimosingJ H Cross
Scandinavian Journal of Infectious Diseases
J H Braconier, B Christensson
Archives of Internal Medicine
F EscobedoJ Sotelo
© 2022 Meta ULC. All rights reserved